Zvonimir Vrselja, MD, PhD

Zvonimir Vrselja, MD, PhD is the Chief Executive Officer of Bexorg, Inc., a techbio company pioneering the use of perfused postmortem human brains for CNS drug discovery. A scientist-entrepreneur with extensive experience in clinical medicine, neuroanatomy, and organ perfusion, he co-invented BrainEx at Yale University—the first system to restore cellular and molecular brain activity after death, published in Nature. At Bexorg, he built the XO Digital platform that integrates multimodal human brain data into AI foundation models to map causal biology and accelerate target discovery, initiated internal drug discovery programs, and established partnerships with leading pharmaceutical companies. Dr. Vrselja earned his MD and PhD and trained in clinical radiology at J. J. Strossmayer University in Croatia. His work has been featured in Nature and Science, earning recognition as a Schmidt Futures Innovation Fellow and finalist for the Eppendorf & Science Prize for Neurobiology.